Background
Hypoxia induces the transcription of various genes involved in angiogenesis and anaerobic metabolism necessary for the growth of tumor cells. Hypoxia-inducible factor 1 alpha (HIF-1α) regulates genes involved in the response to hypoxia and promotes neo-angiogenesis in cancer. Thus, to develop an anticancer agent with anti-angiogenic activity in hypoxic cancer cells, 6-(1-oxobutyl)-5,8-dimetoxy-1,4-naphthoquinone (OXO) was synthesized.
Methods
The XTT (2,3-bis [2-methoxy-4-nitro-5-sulfophenyl]-2H-tetra-zolium-5-carboxanilide) assay for cytotoxicity, the ELISA, RT-PCR and western blotting analysis were employed in MCF-7 human breast cancer cells under hypoxic conditions.
Results
OXO showed cytotoxicity against MCF-7 cells, human breast M. OXO also reduced the levels cancer cells with an IC50 value of 10 μ of vascular endothelial cell growth factor (VEGF) and HIF-1α in MCF cells exposed to hypoxia. Similarly, OXO downregulated the expression of HIF-1 and VEGF by western blotting and RT-PCR. In addition, OXO inhibited the basic fibroblast growth factor (bFGF)-induced proliferation, inhibited tube formation of human umbilical vein endothelial cells (HUVECs) and also disrupted the neovascularization in bFGF-treated Matrigel in vivo.
Conclusion
Taken together, these results show that OXO may exert anti-tumor and anti-angiogenic activity against MCF-7 cells via regulation of HIF-1α and VEGF.
Figure 1.
Cytotoxicity.
Figure 2.
Effect of OXO on the proliferation of bFGF-treated HUVECs.
Figure 3.
Effect of OXO on the tube formation of bFGF-treated HUVECs.
Figure 4.
Effect of OXO on VEGF and HIF-1α in MCF-7 cells exposed to hypoxia.
Figure 5.
Effect of OXO on the content of hemoglobin in bFGF-treated Matrigel.
References
- Song G-Y, Kim Y, You YJ, Cho H, Kim SH, Sok DE, Ahn BZ. Naphtazarin derivatives (VI): synthesis, inhibitory effect on DNA topoisomerase-I and antiproliferative activity of 2- or 6-(1-oxyiminoalkyl)-5,8-dimethoxy-1,4-napthoquinones. Arch Pharm Pharm Med Chem. 2000;333:87–92. doi: 10.1002/(SICI)1521-4184(20004)333:4<87::AID-ARDP87>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
- Forsythe JA, Jiang BH, Lyer NV, Agani F, Leung SW, Koos RD. et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16:4604–4613. doi: 10.1128/mcb.16.9.4604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Richard DE, Berra E, Pouyssegur J. Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res Commun. 1999;266:718–722. doi: 10.1006/bbrc.1999.1889. [DOI] [PubMed] [Google Scholar]
- Ferrara H, Gerber H-P, Lecouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669–676. doi: 10.1038/nm0603-669. [DOI] [PubMed] [Google Scholar]